MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ctm2.1025

Медицинская библиотека · Clinical and translational medicine · 2022

Mitochondrial regulation of acute extrafollicular B-cell responses to COVID-19 severity.

Cao Tianyu, Liu Li, To Kelvin Kai-Wang, Lim Chun-Yu, Zhou Runhong, Ming Yue, Kwan Ka-Yi, Yu Sulan, Chan Chun-Yin, Zhou Biao, Huang Haode, Mo Yufei, Du Zhenglong, Gong Ruomei, Yat Luk-Tsz, Hung Ivan Fan-Ngai, Tam Anthony Raymond, To Wing-Kin, Leung Wai-Shing, Chik Thomas Shiu-Hong, Tsang Owen Tak-Yin, Lin Xiang, Song You-Qiang, Yuen Kwok-Yung, Chen Zhiwei

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Patients with COVID-19 display a broad spectrum of manifestations from asymptomatic to life-threatening disease with dysregulated immune responses. Mechanisms underlying the detrimental immune responses and disease severity remain elusive.

METHODS

We investigated a total of 137 APs infected with SARS-CoV-2. Patients were divided into mild and severe patient groups based on their requirement of oxygen supplementation. All blood samples from APs were collected within three weeks after symptom onset. Freshly isolated PBMCs were investigated for B cell subsets, their homing potential, activation state, mitochondrial functionality and proliferative response. Plasma samples were tested for cytokine concentration, and titer of Nabs, RBD-, S1-, SSA/Ro- and dsDNA-specific IgG.

RESULTS

While critically ill patients displayed predominantly extrafollicular B cell activation with elevated inflammation, mild patients counteracted the disease through the timely induction of mitochondrial dysfunction in B cells within the first week post symptom onset. Rapidly increased mitochondrial dysfunction, which was caused by infection-induced excessive intracellular calcium accumulation, suppressed excessive extrafollicular responses, leading to increased neutralizing potency index and decreased inflammatory cytokine production. Patients who received prior COVID-19 vaccines before infection displayed significantly decreased extrafollicular B cell responses and mild disease.

CONCLUSION

Our results reveal an immune mechanism that controls SARS-CoV-2-induced detrimental B cell responses and COVID-19 severity, which may have implications for viral pathogenesis, therapeutic interventions and vaccine development.

Для цитирования: Cao Tianyu, Liu Li, To Kelvin Kai-Wang, Lim Chun-Yu, Zhou Runhong, Ming Yue, Kwan Ka-Yi, Yu Sulan, Chan Chun-Yin, Zhou Biao, Huang Haode, Mo Yufei, Du Zhenglong, Gong Ruomei, Yat Luk-Tsz, Hung Ivan Fan-Ngai, Tam Anthony Raymond, To Wing-Kin, Leung Wai-Shing, Chik Thomas Shiu-Hong, Tsang Owen Tak-Yin, Lin Xiang, Song You-Qiang, Yuen Kwok-Yung, Chen Zhiwei. Mitochondrial regulation of acute extrafollicular B-cell responses to COVID-19 severity.. Clinical and translational medicine. 2022. DOI: 10.1002/ctm2.1025.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.